Le Lézard
Classified in: Health
Subjects: HEALTH, GOVERNMENT CONTRACTS

Nikkiso Cryogenic Services Recommissioned Air Separation Plant in India for Critical Oxygen Supply


TEMECULA, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Nikkiso Cryogenic Industries' Clean Energy & Industrial Gases Group (Group), a subsidiary of Nikkiso Co., Ltd (Japan), is proud to announce they have completed the recommissioning of an Air Separation plant in Patancheru, Hyderabad India. This project was done in coordination with the Telangana government (TEL), and Greenko Foundation (GKO).

Due to the ongoing pandemic crisis in India, the Indian government initiated a directive to restart the operation and LOX production to meet the urgent demands for medical oxygen. GKO has taken the old shut-down Oxygen plant on rental basis from Air Water India Private Limited (AWI) for period of (2) two years.

In May 2021, the Group partnered along with GKO in recommissioning of the plant. Nikkiso Cryogenic Services provided critical technical support and spare parts, including nozzle actuators and vibration components, and Nikkiso Cosmodyne India Pvt. Ltd. provided field service support. Critical components which typically take 12-14 weeks were provided in three days to support this urgent request. By June 22nd, the site was fully operational again.

"We are proud to have played a role in this fight against COVID, and of the technology and teamwork it took to get this facility up and running in such short time," according to Jim Estes, President, Nikkiso Cryogenic Services.

The Group has been instrumental in providing continuous global support for the critical oxygen supply throughout the COVID epidemic.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture engineered cryogenic gas processing equipment and small-scale process plants for the liquefied natural gas (LNG), well services and industrial gas industries. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Cosmodyne and Cryoquip and a commonly-controlled group of approximately 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:

Anna Quigley
+1.951.383.3314
[email protected]



These press releases may also interest you

at 12:05
The Police Benevolent Association of the City of New York (PBA) has been honored with the Kidneys for Communities National Community Impact Award in recognition of its dedication and commitment to promoting living kidney donation and supporting the...

at 12:01
INITIATION NOTE: BrainStorm Cell Therapeutics Inc.  is focused on developing autologous mesenchymal stem cell (MSC) therapies for the treatment of neurodegenerative diseases (NDDs) ? BCLI's primary...

at 12:01
The board of directors of Abbott today declared a quarterly common dividend of 55 cents per share. This marks the 402nd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug. 15, 2024, to shareholders of...

at 12:00
Sleep Doctor, the leading online source for sleep health, improvement, and education, has published a recent survey report examining the relationship between sleep and work. The report also provides insights into the sleep disparities between men and...

at 12:00
Being physically active helps to improve our physical and mental health. Regular physical activity can also help to prevent chronic disease. That's why the Government of Canada is proud to invest in community-based initiatives that are providing more...

at 12:00
Revolutionizing Children's Health Understanding the importance of...



News published on and distributed by: